Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
The ministry of heavy industries, the nodal agency for the PLI scheme, has sought inputs from the Society of Indian ...
Investors have responded positively to this healthcare stock's announcement. The post This ASX 300 stock is racing 6% higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback